These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26935532)

  • 1. Changes in Prescribed Drugs Between Admission and the End of Life in Patients Admitted to Palliative Care Facilities.
    van Nordennen RT; Lavrijsen JC; Heesterbeek MJ; Bor H; Vissers KC; Koopmans RT
    J Am Med Dir Assoc; 2016 Jun; 17(6):514-8. PubMed ID: 26935532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Burden of Polypharmacy in Patients Near the End of Life.
    McNeil MJ; Kamal AH; Kutner JS; Ritchie CS; Abernethy AP
    J Pain Symptom Manage; 2016 Feb; 51(2):178-83.e2. PubMed ID: 26432571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription trends at the end of life in a palliative care unit: observational study.
    Peralta T; Castel-Branco MM; Reis-Pina P; Figueiredo IV; Dourado M
    BMC Palliat Care; 2022 May; 21(1):65. PubMed ID: 35505394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication use during end-of-life care in a palliative care centre.
    Masman AD; van Dijk M; Tibboel D; Baar FP; Mathôt RA
    Int J Clin Pharm; 2015 Oct; 37(5):767-75. PubMed ID: 25854310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy and medication errors on admission to palliative care.
    Grądalski T
    Pol Arch Intern Med; 2019 Oct; 129(10):659-666. PubMed ID: 31502585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life.
    Vitetta L; Kenner D; Sali A
    Am J Hosp Palliat Care; 2005; 22(6):465-73. PubMed ID: 16323717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Preventive and Symptomatic Drug Treatments in Hospice Care: An Italian Observational Study.
    Pasina L; Recchia A; Agosti P; Nobili A; Rizzi B
    Am J Hosp Palliat Care; 2019 Mar; 36(3):216-221. PubMed ID: 30114944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus.
    Morin L; Laroche ML; Vetrano DL; Fastbom J; Johnell K
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1333-1342. PubMed ID: 29934849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study.
    Morin L; Vetrano DL; Rizzuto D; Calderón-Larrañaga A; Fastbom J; Johnell K
    Am J Med; 2017 Aug; 130(8):927-936.e9. PubMed ID: 28454668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication use in nursing home residents with advanced dementia.
    Blass DM; Black BS; Phillips H; Finucane T; Baker A; Loreck D; Rabins PV
    Int J Geriatr Psychiatry; 2008 May; 23(5):490-6. PubMed ID: 17944007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing for comorbid disease in a palliative population: focus on the use of lipid-lowering medications.
    Russell BJ; Rowett D; Abernethy AP; Currow DC
    Intern Med J; 2014 Feb; 44(2):177-84. PubMed ID: 24341863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing in palliative care as death approaches.
    Currow DC; Stevenson JP; Abernethy AP; Plummer J; Shelby-James TM
    J Am Geriatr Soc; 2007 Apr; 55(4):590-5. PubMed ID: 17397439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication appropriateness for patients with dementia approaching the end of their life.
    Chuang HY; Wen YW; Chen LK; Hsiao FY
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():65-74. PubMed ID: 28436189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-Label Medication Use in the Inpatient Palliative Care Unit.
    Kwon JH; Kim MJ; Bruera S; Park M; Bruera E; Hui D
    J Pain Symptom Manage; 2017 Jul; 54(1):46-54. PubMed ID: 28479415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in medication profile among patients with advanced cancer admitted to an acute palliative care unit.
    Hui D; Li Z; Chisholm GB; Didwaniya N; Bruera E
    Support Care Cancer; 2015 Feb; 23(2):427-32. PubMed ID: 25123192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision making about change of medication for comorbid disease at the end of life: an integrative review.
    van Nordennen RT; Lavrijsen JC; Vissers KC; Koopmans RT
    Drugs Aging; 2014 Jul; 31(7):501-12. PubMed ID: 24825615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program.
    Jódar-Sánchez F; Malet-Larrea A; Martín JJ; García-Mochón L; López Del Amo MP; Martínez-Martínez F; Gastelurrutia-Garralda MA; García-Cárdenas V; Sabater-Hernández D; Sáez-Benito L; Benrimoj SI
    Pharmacoeconomics; 2015 Jun; 33(6):599-610. PubMed ID: 25774017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom Assessment for a Palliative Care Approach in People With Dementia Admitted to Acute Hospitals: Results From a National Audit.
    O'Shea E; Timmons S; Kennelly S; de Siún A; Gallagher P; O'Neill D
    J Geriatr Psychiatry Neurol; 2015 Dec; 28(4):255-9. PubMed ID: 26047636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate medication use and polypharmacy in end-stage cancer patients: Isn't it the family doctor's role to de-prescribe much earlier?
    Garfinkel D; Ilin N; Waller A; Torkan-Zilberstein A; Zilberstein N; Gueta I
    Int J Clin Pract; 2018 Apr; 72(4):e13061. PubMed ID: 29359381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentially inappropriate medication at hospital admission in patients with palliative care needs.
    Sevilla-Sánchez D; Molist-Brunet N; Amblàs-Novellas J; Espaulella-Panicot J; Codina-Jané C
    Int J Clin Pharm; 2017 Oct; 39(5):1018-1030. PubMed ID: 28744675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.